JP2023517729A5 - - Google Patents
Info
- Publication number
- JP2023517729A5 JP2023517729A5 JP2022555821A JP2022555821A JP2023517729A5 JP 2023517729 A5 JP2023517729 A5 JP 2023517729A5 JP 2022555821 A JP2022555821 A JP 2022555821A JP 2022555821 A JP2022555821 A JP 2022555821A JP 2023517729 A5 JP2023517729 A5 JP 2023517729A5
- Authority
- JP
- Japan
- Prior art keywords
- process according
- disorders
- pharmaceutical composition
- monohydrochloride salt
- crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025132332A JP2025166092A (ja) | 2020-03-19 | 2025-08-07 | Ｔａａｒ１アゴニストの塩形態および結晶形態 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20164069 | 2020-03-19 | ||
| EP20164069.5 | 2020-03-19 | ||
| PCT/EP2021/056749 WO2021185878A1 (en) | 2020-03-19 | 2021-03-17 | Salts and crystalline forms of a taar1 agonist |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025132332A Division JP2025166092A (ja) | 2020-03-19 | 2025-08-07 | Ｔａａｒ１アゴニストの塩形態および結晶形態 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023517729A JP2023517729A (ja) | 2023-04-26 |
| JP2023517729A5 true JP2023517729A5 (https=) | 2024-03-26 |
Family
ID=69846246
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022555821A Pending JP2023517729A (ja) | 2020-03-19 | 2021-03-17 | Ｔａａｒ１アゴニストの塩形態および結晶形態 |
| JP2025132332A Pending JP2025166092A (ja) | 2020-03-19 | 2025-08-07 | Ｔａａｒ１アゴニストの塩形態および結晶形態 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025132332A Pending JP2025166092A (ja) | 2020-03-19 | 2025-08-07 | Ｔａａｒ１アゴニストの塩形態および結晶形態 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230120311A1 (https=) |
| EP (1) | EP4121428B1 (https=) |
| JP (2) | JP2023517729A (https=) |
| KR (1) | KR20220155575A (https=) |
| CN (1) | CN115279752A (https=) |
| AU (1) | AU2021238632A1 (https=) |
| BR (1) | BR112022016746A2 (https=) |
| CA (1) | CA3166331A1 (https=) |
| ES (1) | ES3044409T3 (https=) |
| IL (1) | IL294301A (https=) |
| MX (1) | MX2022010794A (https=) |
| TW (1) | TWI874616B (https=) |
| WO (1) | WO2021185878A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4731191A1 (en) * | 2022-08-12 | 2026-04-29 | F. Hoffmann-La Roche AG | Pharmaceutical compositions comprising 5-ethyl-4-methyl- n-[4-[(2 s) morpholin-2-yl]phenyl]-1h-pyrazole-3-carboxamide |
| WO2024222860A1 (zh) * | 2023-04-28 | 2024-10-31 | 江苏豪森药业集团有限公司 | 一种吗啉杂环类化合物的盐及其制备方法和应用 |
| CN117903050B (zh) * | 2024-03-15 | 2024-05-17 | 中国药科大学 | 阿立哌唑共晶及其药物组合物和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5323907A (en) | 1992-06-23 | 1994-06-28 | Multi-Comp, Inc. | Child resistant package assembly for dispensing pharmaceutical medications |
| CN108713019B (zh) * | 2016-03-17 | 2021-06-15 | 豪夫迈·罗氏有限公司 | 具有作为taar的激动剂的活性的5-乙基-4-甲基-吡唑-3-甲酰胺衍生物 |
-
2021
- 2021-03-17 EP EP21712158.1A patent/EP4121428B1/en active Active
- 2021-03-17 IL IL294301A patent/IL294301A/en unknown
- 2021-03-17 BR BR112022016746A patent/BR112022016746A2/pt unknown
- 2021-03-17 ES ES21712158T patent/ES3044409T3/es active Active
- 2021-03-17 TW TW110109520A patent/TWI874616B/zh active
- 2021-03-17 CA CA3166331A patent/CA3166331A1/en active Pending
- 2021-03-17 KR KR1020227031814A patent/KR20220155575A/ko active Pending
- 2021-03-17 WO PCT/EP2021/056749 patent/WO2021185878A1/en not_active Ceased
- 2021-03-17 CN CN202180017438.9A patent/CN115279752A/zh active Pending
- 2021-03-17 AU AU2021238632A patent/AU2021238632A1/en active Pending
- 2021-03-17 MX MX2022010794A patent/MX2022010794A/es unknown
- 2021-03-17 JP JP2022555821A patent/JP2023517729A/ja active Pending
-
2022
- 2022-09-16 US US17/946,743 patent/US20230120311A1/en active Pending
-
2025
- 2025-08-07 JP JP2025132332A patent/JP2025166092A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI322805B (https=) | ||
| JP2023517729A5 (https=) | ||
| CN1582278A (zh) | 多晶型rimonabant,其制备方法及含有它的药物组合物 | |
| CN1612863A (zh) | 氘代的取代的吡唑基－苯磺酰胺以及包含该化合物的药物组合物 | |
| TW201033181A (en) | Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine | |
| JP2011529480A (ja) | ラサジリンメシレートの多型 | |
| WO2016107289A1 (zh) | 制备索非布韦晶型6的方法 | |
| CN1602304A (zh) | 氘代的取代的二氢呋喃酮以及包含该化合物的药物组合物 | |
| CN1443178A (zh) | (r)－n－[5－甲基－8－(4－甲基哌嗪－1－基)－1,2,3,4－四氢－2－萘基]－4－吗啉代苯甲酰胺的新形态 | |
| CN1805953A (zh) | 用作血清素再摄取抑制剂的吲哚衍生物 | |
| US20100035994A1 (en) | Novel hydrate form of o-desmethyl venlafaxine succinate | |
| KR101557832B1 (ko) | (ｒ)-3-플루오로페닐-3,4,5-트리플루오로벤질카르밤산 1-아자비시클로 [2.2.2]옥트-3-일 에스테르의 안정한 결정성 염 | |
| CN1452614A (zh) | 芳基哌嗪衍生物及其作为精神药物的用途 | |
| FR2643634A1 (fr) | Nouveaux derives benzoxazolinoniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
| TW200817322A (en) | Compounds having activity at the GlyT1 transporter | |
| US20080153848A1 (en) | Crystalline Base of Trans-1-((1R,3S)-6-Chloro-3-Phenylindan-1-Yl)-3,3-Dimethylpiperazine | |
| CN1880294B (zh) | 右酮洛芬氨丁三醇的多晶型、其制备方法和包含它的组合物 | |
| JP2004526692A (ja) | 純粋な塩酸オンダンセトロン二水和物を製造するための改良された方法 | |
| JPS584765A (ja) | 新規インド−ル誘導体、その製法及び該化合物を含有するβ−受容体刺激性、抗アレルギ−性、消炎性及び鎮痛性医薬調剤 | |
| CN119039301B (zh) | 一种含氮杂环的多环化合物晶型ⅰ的制备方法 | |
| TWI787008B (zh) | 右美托咪定鹽酸鹽之製造方法 | |
| TWI886914B (zh) | -3-酮衍生物枸櫞酸鹽的晶型、製備方法及其用途 | |
| CN1029737C (zh) | 新氨烷基酮衍生物的制备方法 | |
| WO2009110519A1 (ja) | 新規１－アミノカルボニルピペリジン誘導体 | |
| JP6595990B2 (ja) | アゴメラチンとスルホン酸との新規な複合体、これらの製造方法及びこれらを含有する医薬組成物 |